Condition: Aortic Valve Insufficiency · Aortic Valve Stenosis · Sponsor: Edwards Lifesciences
The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4/X4S Transcatheter Heart Valve (THV) in subjects who are at high or greater risk with a failing aortic bioprosthetic valve.
This description comes directly from the study's public registry record.
Edwards THV Clinical Affairs · 949-250-2500 · THV_CT.gov@Edwards.com
Always discuss trial participation with your own doctor first.
| Hoag Memorial Hospital Presbyterian | Newport Beach, California, United States | Recruiting |
| Bay Area Structural Heart at Sutter Health | San Francisco, California, United States | Recruiting |
| Kaiser San Francisco | San Francisco, California, United States | Recruiting |
| Stanford University Medical Center | Stanford, California, United States | Recruiting |
| UC Health Medical Center of the Rockies | Loveland, Colorado, United States | Recruiting |
| Naples Community Hospital Healthcare System | Naples, Florida, United States | Recruiting |
| Emory University Atlanta | Atlanta, Georgia, United States | Recruiting |
| Piedmont Heart Institute | Atlanta, Georgia, United States | Recruiting |
| Northwestern University Chicago | Evanston, Illinois, United States | Recruiting |
| Alexian Brothers Hospital Network | Lisle, Illinois, United States | Recruiting |
| Cardiovascular Research Institute of Kansas | Wichita, Kansas, United States | Recruiting |
| MedStar Union Memorial Hospital | Baltimore, Maryland, United States | Recruiting |
+ 24 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05172973